Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis
Open Access
- 1 November 2004
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 279 (48), 50537-50554
- https://doi.org/10.1074/jbc.m406454200
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Interaction between Hex and GATA Transcription Factors in Vascular Endothelial Cells Inhibits flk-1/KDR-mediated Vascular Endothelial Growth Factor SignalingPublished by Elsevier BV ,2004
- A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferationBiochemical Journal, 2002
- Regulation of Angiogenesis by Glycogen Synthase Kinase-3βPublished by Elsevier BV ,2002
- Calcineurin-GATA-6 pathway is involved in smooth muscle–specific transcriptionThe Journal of cell biology, 2002
- Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATcPublished by Elsevier BV ,2001
- Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2Science, 1999
- TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and FunctionAnnual Review of Immunology, 1997
- The Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4Cell, 1996
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.Genes & Development, 1989